Literature DB >> 10695481

Control of smooth muscle cell proliferation--the role of the basement membrane.

U Hedin1, J Roy, P K Tran, K Lundmark, A Rahman.   

Abstract

In atherogenesis and in response to vessel injury, arterial smooth muscle cells (SMCs) are activated from a quiescent, differentiated state into an actively proliferating and synthetic phenotype which migrate into the intima where the cells participate in the formation of a fibrous plaque or intimal hyperplasia. The mechanisms involved in the control of SMC function are not clear and no preventive therapy against SMC activation is available. Interactions between SMCs and the extracellular matrix have been shown to influence SMC structure and function through integrin-mediated signaling processes. The SMC basement membrane is a specific form of extracellular matrix which seems to be crucial for the maintenance of SMC quiescence and the disruption of these interactions is part of cellular activation after atherogenic or traumatic stimuli. This concept of "negative growth control" may constitute a future target for the development of new strategies in the prevention of SMC activation in atherogenesis and restenosis formation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10695481

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  15 in total

1.  FRNK overexpression limits the depth and frequency of vascular smooth muscle cell invasion in a three-dimensional fibrin matrix.

Authors:  L P Brewster; A A Ucuzian; E M Brey; M Liwanag; A M Samarel; H P Greisler
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

Review 2.  The pathogenesis of vascular calcification in the chronic kidney disease mineral bone disorder: the links between bone and the vasculature.

Authors:  Keith A Hruska; Suresh Mathew; Richard J Lund; Imran Memon; Georges Saab
Journal:  Semin Nephrol       Date:  2009-03       Impact factor: 5.299

3.  TGFBR1 is required for mouse myometrial development.

Authors:  Yang Gao; Kayla J Bayless; Qinglei Li
Journal:  Mol Endocrinol       Date:  2014-02-07

4.  The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.

Authors:  Megan S Lord; Christine Y Chuang; James Melrose; Michael J Davies; Renato V Iozzo; John M Whitelock
Journal:  Matrix Biol       Date:  2014-02-06       Impact factor: 11.583

Review 5.  Bone morphogenetic protein signaling in inflammation.

Authors:  David H Wu; Antonis K Hatzopoulos
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-07

6.  Enhanced proliferation and migration of vascular smooth muscle cells in response to vascular injury under hyperglycemic conditions is controlled by beta3 integrin signaling.

Authors:  Manikandan Panchatcharam; Sumitra Miriyala; Fanmuyi Yang; Michael Leitges; Magdalena Chrzanowska-Wodnicka; Lawrence A Quilliam; Paul Anaya; Andrew J Morris; Susan S Smyth
Journal:  Int J Biochem Cell Biol       Date:  2010-02-23       Impact factor: 5.085

Review 7.  Cardiovascular gene delivery: The good road is awaiting.

Authors:  L P Brewster; E M Brey; H P Greisler
Journal:  Adv Drug Deliv Rev       Date:  2006-07-07       Impact factor: 15.470

8.  Tropoelastin inhibits intimal hyperplasia of mouse bioresorbable arterial vascular grafts.

Authors:  Tadahisa Sugiura; Riddhima Agarwal; Shuhei Tara; Tai Yi; Yong-Ung Lee; Christopher K Breuer; Anthony S Weiss; Toshiharu Shinoka
Journal:  Acta Biomater       Date:  2016-12-23       Impact factor: 8.947

9.  Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin.

Authors:  Daria K Moaveni; Erin M Lynch; Cathy Luke; Vikram Sood; Gilbert R Upchurch; Thomas W Wakefield; Peter K Henke
Journal:  J Vasc Surg       Date:  2008-03       Impact factor: 4.268

10.  Syndecan-1 in mechanosensing of nanotopological cues in engineered materials.

Authors:  Victoria Le; Jason Lee; Somali Chaterji; Adrianne Spencer; Yen-Liang Liu; Peter Kim; Hsin-Chih Yeh; Deok-Ho Kim; Aaron B Baker
Journal:  Biomaterials       Date:  2017-11-09       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.